Mobilization of human lymphoid progenitors after treatment with granulocyte colony-stimulating factor

Journal of Immunology

Volumn 175, Issue 4, 2005, Pages 2647-2654

  Imamura, Rie ^a,b,c   Miyamoto, Toshihiro ^a,b   Yoshimoto, Goichi ^b   Kamezaki, Kenjiro ^a,b   Ishikawa, Fumihiko ^b   Henzan, Hideho ^a,b   Kato, Koji ^b   Takase, Ken ^a,b   Numata, Akihiko ^a,b   Nagafuji, Koji ^b   Okamura, Takashi ^c   Sata, Michio ^c   Harada, Mine ^b   Inaba, Shoichi ^a,d  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Kanagawa Red Cross Hospital Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOMODULATION; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR GENE; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION;

EID: 23444458925     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.4.2647     Document Type: Article

References (51)

1. To, L. B., D. N. Haylock, P. J. Simmons, and C. A. Juttner. 1997. The biology and clinical uses of blood stem cells. Blood 89: 2233-2258.
2. Avalos, B. R. 1996. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 88: 761-777.
3. Akashi, K., D. Traver, T. Miyamoto, and I. L. Weissman. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404: 193-197.
4. Miyamoto, T., H. Iwasaki, B. Reizis, M. Ye, T. Graf, I. L. Weissman, and K. Akashi. 2002. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev. Cell 3: 137-147.
5. Liu, F., J. Poursine-Laurent, and D. C. Link. 2000. Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF. Blood 95: 3025-3031.
6. Semerad, C. L., F. Liu, A. D. Gregory, K. Stumpf, and D. C. Link. 2002. G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity 17: 413-423.
7. Link, D. C. 2000. Mechanisms of granulocyte colony-stimulating factor-induced hematopoietic progenitor-cell mobilization. Semin. Hematol. 37: 25-32.
8. Lapidot, T., and I. Petit. 2002. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 30: 973-981.
9. Thomas, J., F. Liu, and D. C. Link. 2002. Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor. Curr. Opin. Hematol. 9: 183-189.
10. Hattori, K., B. Heissig, and S. Rafii. 2003. The regulation of hematopoietic stem cell and progenitor mobilization by chemokine SDF-1. Leuk. Lymphoma 44: 575-582.
11. Papayannopoulou, T. 2004. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 103: 1580-1585.
12. Miyamoto, T., I. L. Weissman, and K. Akashi. 2000. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl. Acad. Sci. USA 97: 7521-7526.
13. Manz, M. G., T. Miyamoto, K. Akashi, and I. L. Weissman. 2002. Prospective isolation of human clonogenic common myeloid progenitors. Proc. Natl. Acad. Sci. USA 99: 11872-11877.
14. Galy, A., M. Travis, D. Cen, and B. Chen. 1995. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3: 459-473.
15. Itoh, K., H. Tezuka, H. Sakoda, M. Konno, K. Nagata, T. Uchiyama, H. Uchino, and K. J. Mori. 1989. Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp. Hematol. 17: 145-153.
16. null mice. Exp. Hematol. 30: 488-494.
17. + cells. Blood 90: 4014-4021.
18. Reynaud, D., N. Lefort, E. Manie, L. Coulombel, and Y. Levy. 2003. In vitro identification of human pro-B cells that give rise to macrophages, natural killer cells, and T cells. Blood 101: 4313-4321.
19. Kondo, M., I. L. Weissman, and K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661-672.
20. LeBien, T. W. 2000. Fates of human B-cell precursors. Blood 96: 9-23.
21. Hao, Q. L., J. Zhu, M. A. Price, K. J. Payne, L. W. Barsky, and G. M. Crooks. 2001. Identification of a novel, human multilymphoid progenitor in cord blood. Blood 97: 3683-3690.
22. Nagasawa, T., S. Hirota, K. Tachibana, N. Takakura, S. Nishikawa, Y. Kitamura, N. Yoshida, H. Kikutani, and T. Kishimoto. 1996. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382: 635-638.
23. Li, Y. S., K. Hayakawa, and R. R. Hardy. 1993. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J. Exp. Med. 178: 951-960.
24. Ghia, P., E. ten Boekel, E. Sanz, A. de la Hera, A. Rolink, and F. Melchers. 1996. Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci. J. Exp. Med. 184: 2217-2229.
25. Levesque, J. P., Y. Takamatsu, S. K. Nilsson, D. N. Haylock, and P. J. Simmons. 2001. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98: 1289-1297.
26. Heissig, B., K. Hattori, S. Dias, M. Friedrich, B. Ferris, N. R. Hackett, R. G. Crystal, P. Besmer, D. Lyden, M. A. Moore, et al. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109: 625-637.
27. Levesque, J. P., J. Hendy, Y. Takamatsu, B. Williams, I. G. Winkler, and P. J. Simmons. 2002. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp. Hematol. 30: 440-449.
28. Petit, I., M. Szyper-Kravitz, A. Nagler, M. Lahav, A. Peled, L. Habler, T. Ponomaryov, R. S. Taichman, F. Arenzana-Seisdedos, N. Fujii, et al. 2002. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3: 687-694.
29. Levesque, J. P., J. Hendy, Y. Takamatsu, P. J. Simmons, and L. J. Bendall. 2003. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 111: 187-196.
30. Levesque, J. P., J. Hendy, I. G. Winkler, Y. Takamatsu, and P. J. Simmons. 2003. Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT-receptor (CD117) from the surface of hematopoietic progenitor cells. Exp. Hematol. 31: 109-117.
31. + cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies. J. Hematother. Stem Cell Res. 12: 425-434.
32. 1 integrin expression and function. J. Clin. Invest. 101: 2456-2467.
33. + cells during mobilization with G-CSF. Bone Marrow Transplant. 23: 1-8.
34. + cells predict a rapid platelet recovery after peripheral blood stem cell transplantation. Blood 85: 3313-3319.
35. + cells. Int. J. Hematol. 71: 328-333.
36. + hematopoietic stem cells. Blood 99: 2037-2044.
37. + hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood. J. Hematother. 2: 483-489.
38. + cells. Blood 84: 2930-2939.
39. Ma, Q., D. Jones, P. R. Borghesani, R. A. Segal, T. Nagasawa, T. Kishimoto, R. T. Bronson, and T. A. Springer. 1998. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. USA 95: 9448-9453.
40. Ma. Q., D. Jones, and T. A. Springer. 1999. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10: 463-471.
41. Roberts, A. W., and D. Metcalf. 1995. Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood 86: 1600-1605.
42. Nutt, S. L., B. Heavey, A. G. Rolink, and M. Busslinger. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401: 556-562.
43. Rolink, A. G., S. L. Nutt, F. Melchers, and M. Busslinger. 1999. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 401: 603-606.
44. Kondo, M., D. C. Scherer, T. Miyamoto, A. G. King, K. Akashi, K. Sugamura, and I. L. Weissman. 2000. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 407: 383-386.
45. Iwasaki, H., S. Mizuno, R. A. Wells, A. B. Cantor, S. Watanabe, and K. Akashi. 2003. GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages. Immunity 19: 451-462.
46. Iwasaki-Arai, J., H. Iwasaki, T. Miyamoto, S. Watanabe, and K. Akashi. 2003. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic-lineage conversion. J. Exp. Med. 197: 1311-1322.
47. Calvi, L. M., G. B. Adams, K. W. Weibrecht, J. M. Weber, D. P. Olson, M. C. Knight, R. P. Martin, E. Schipani, P. Divieti, F. R. Bringhurst, et al. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841-846.
48. Zhang, J., C. Niu, L. Ye, H. Huang, X. He, W. G. Tong, J. Ross, J. Haug, T. Johnson, J. Q. Feng, et al. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425: 836-841.
49. Inaba, S., K. Egashira, and K. Komori. 2002. Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis? Lancet 360: 2083.
50. + cells in normal donors treated with filgrastim. Transfusion 37: 507-512.
51. Stiff, P., R. Gingrich, S. Luger, M. R. Wyres, R. A. Brown, C. F. LeMaistre, J. Perry, D. P. Schenkein, A. List, J. R. Mason, et al. 2000. A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma. Bone Marrow Transplant. 26: 471-481.